510(k) K897133

MODEL 1050 - UMBILICAL CORD BLOOD SAMPLING KIT by Transidyne General Corp. — Product Code CBT

K897133 is an FDA 510(k) premarket notification submitted by Transidyne General Corp. for the device "MODEL 1050 - UMBILICAL CORD BLOOD SAMPLING KIT". The FDA issued a decision of Substantially Equivalent on Mar 30, 1990. The device falls under product code CBT (Arterial Blood Sampling Kit), a Class I device regulated under 21 CFR 868.1100. Transidyne General Corp. has 20 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 30, 1990
Date Received
Dec 27, 1989
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Arterial Blood Sampling Kit
Device Class
Class I
Regulation Number
868.1100
Review Panel
AN
Submission Type
Enforcement Discretion

This product code has been established in accordance with the may 20, 1997, guidance entitled, convenience kits interim regulatory guidance, found at www.Fda.Gov/cdrh/ode/convkit.Html. This type of convenience kit, as listed in the guidance above, is under enforcement discretion, and does not require a premarket notification (510(k)) to market if it meets all criteria in the guidance.

Need the full FDA record for Transidyne General Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K897133. Report a data issue: hello@regdatalab.com.